ArticleCancer chemotherapy and pharmacology2021

Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neck.

Sema Sezgin Göksu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.